Dermascan
Create skin cancer screening facilities where technological innovation optimises access to care for patients and the working environment for practitioners.
Dermascan builds and operates medical centers specialised in skin cancer screening that allows for earlier detection through complete body mapping and dermoscopic analysis of suspicious lesions.
The challenge they want to solve
Currently, one out of three cancers is cutaneous, but we’re facing a shortage in dermatologists and long waiting times to get a consultation. In this context, Dermascan tackles the challenge of skin cancer detection by offering a faster “first step detection” powered by AI.
The impact they have
Dermascan democratises access to screening and contributes to the early detection of skin cancers, thereby reducing inequalities in care.
The way we measure it
We measure the number of screenings performed each year, the number of patients sent to a specialist for skin cancer suspicions and the reduction in the average waiting time to obtain a consultation. Dermascan also assesses the sensitivity and specificity of AI diagnosis.
